Comparison of efficacy, tolerability, and cost of iron polymaltose complex with ferrous sulphate in the treatment of iron deficiency anemia in pregnant women

MedGenMed Medscape General Medicine

Volumn 9, Issue 1, 2007, Pages

  Saha, Lekha ^a   Pandhi, Promila ^a   Gopalan, Sarala ^a   Malhotra, Samir ^a   Saha, Pradip Kumar ^b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; FERROUS SULFATE; FOLIC ACID; HEMOGLOBIN; IRON; IRON POLYMALTOSE; FERRIC ION; FERROUS ION;

ACIDITY; ADULT; ARTICLE; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG COST; DRUG EFFICACY; DRUG ERUPTION; DRUG TOLERABILITY; FEMALE; FERRITIN BLOOD LEVEL; GASTRITIS; GESTATION PERIOD; HEARTBURN; HEMATOCRIT; HUMAN; INDIA; IRON BLOOD LEVEL; IRON DEFICIENCY ANEMIA; MAJOR CLINICAL STUDY; MEAN CORPUSCULAR VOLUME; PARALLEL DESIGN; PATIENT COMPLIANCE; PREGNANT WOMAN; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; STUDENT T TEST; TASTE DISORDER; COMPARATIVE STUDY; COST BENEFIT ANALYSIS; ECONOMICS; MULTICENTER STUDY; PREGNANCY; PREGNANCY COMPLICATION;

ADULT; ANEMIA, IRON-DEFICIENCY; COST-BENEFIT ANALYSIS; DOUBLE-BLIND METHOD; FEMALE; FERRIC COMPOUNDS; FERROUS COMPOUNDS; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC;

EID: 33846317100     PISSN: 15310132     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. World Health Organization. Report of a WHO group of experts on nutritional anaemias. Technical report series no.503. Geneva, Switzerland: WHO; 1972.
2. Sharma JB. Nutritional anaemia during pregnancy in non-industrialised countries. In: Studd J, ed. Progress in Obstetrics and Gynaecology. New Delhi: Churchill Livingstone; 2003:103-122
3. Dusch E, Elder L, Achadi E, et al. Women' s perceptions of iron deficiency and anemia prevention and control in eight developing countries. Soc Sci Med. 2002;55:529-544. Abstract
4. Lops VR, Hunter LP, Dixon LR. Anaemia in pregnancy. Am Fam Physician. 1995;94:277-280.
5. Dugdale M. Anaemia. Obstet Gynecol Clin North Am. 2001;28:363-381. Abstract
6. Adamson JW. Iron deficiency and other hypoproliferative anaemias. In: Braunwald E, Fauci AS, Kasper DL, et al, eds. Harrison's Principles of Internal Medicine, 15th edition. Mc Graw Hill, pp 2001,660-66.
7. Sharma N. Iron absorption: IPC therapy is superior to conventional iron salts. Obstet Gynecol. 2001;515-19.
8. McCord JM. Iron, free radicals, and oxidative injury. Semin Hematol. 1998;35:5-12.
9. Geisser P. In vitro studies on interactions of iron salts and complexes with food stuffs and medicaments. Arzneimittelforschung 1990;40:754-760.
10. Jacobs P, Johnson G, Wood L. Oral iron therapy in human subjects, comparative absorption between ferrous salts and iron polymaltose. J Med. 1984;15:367-377. Abstract
11. Maxton DG, Thompson RP, Hinder RC. Absorption of iron from ferric hydroxypyranone complexes. Br J Nutr. 1994;71:203-207. Abstract
12. Jacobs P, Wormald LA, Gregory MC. Absorption of iron polymaltose and ferrous sulphate in rats and humans - a comparative study. S Afr Med J. 1979;26:1065-1072.
13. Rajadhyaksha GC, Shahani S, Pawar D. Evaluation of efficacy and tolerability of iron polymaltose complex tablets in iron deficiency anaemia during pregnancy. JAMA India - the Physicians Update. 2000;3:53-55.
14. Reddy PSN, Adsul BB, Gandewar K, Korde KM, Desai A. Evaluation of efficacy and safety of iron polymaltose complex and folic acid (Mumfer) vs iron formulation (ferrous fumarate) in female patients with anemia. J Indian Med Assoc. 2001;99:154-155. Abstract
15. Jacobs P, Fransman D, Coghlan P. Comparative bioavailability of ferric polymaltose and ferrous sulphate in iron deficient blood donors. J Clin Apheresis. 1993;8:89-95. Abstract
16. Mehta BC. Iron hydroxide polymaltose complex -cause of persistent anemia at delivery. Indian J Med Sci. 2001;55:616-620. Abstract
17. Nielsen P, Gabbe EE, Fischer R, Heinrich HC. Bioavailability of iron from oral ferric polymaltose in humans. Arzneimittelforschung. 1990;40:754-760. Abstract
18. Drabkin DL, Austin JH. Spectrophotometric studies: spectrometric constants for common haemoglobin derivatives in human, dog and rabbit blood. J Biol Chem. 1932;198:719-725.
19. England JM, Walford DM, Waters DAW. Re-assessment of the reliability of the haematocrit. Br J Haematol. 1972;23:247-256. Abstract
20. Tietz NW. In: Tietz NW, ed. Textbook of Clinical Chemistry. Philadelphia, Pa: WB Saunders Co.; 1986: 1578-1583.
21. White D, Kramer D, Johnson G, Dick F, Hamilton H. Estimation of serum ferritin by using enzyme immunoassay method. Am J Clin Pathol. 1986;72:346-351.
22. World Health Organization. The prevalence of anaemia in women: a tabulation of available information. Geneva, Switzerland: WHO; 1992.
23. World Health Organization. Report of working group on iron deficiency anaemia. 1992;1:17-20.
24. Schwartze WJ III, Thurnau GR. Iron deficiency anaemia in pregnancy. Clin Obstet Gynaecol. 1995;38:443-454.
25. Badhwar VR, Rao S, Fonseca MM. Comparative efficacy and safety of iron polymaltose+folic acid and oral ferrous fumarate in the treatment of adult patients with iron deficiency anemia. Indian Med Gazette. 2003;136:296-301.
26. Patkar VD, Patkar S, Khandeparker PS, Dingankar NS, Shetty RS. Evaluation of efficacy and tolerability of iron (III)-hydroxide polymaltose complex tablets in the treatment of iron deficiency anaemia in women. Indian Med Gazette. 2001;135:306-309.
27. Reddy PS, Adsul BB, Gandewar K, Desai A. Mumfer iron polymaltose complex) in the management of anaemia in pregnancy - an Indian study. J Indian Med Assoc. 2000;98:343-346. Abstract
28. Jayaram S, Khandeparkar P, Dingankar NS, Shetty RS. Efficacy and tolerability of iron polymaltose complex in the treatment of iron deficiency anaemia. Indian Med Gazette. 2002;134:234-237.